Steven A. Haney

1.0k total citations
25 papers, 756 citations indexed

About

Steven A. Haney is a scholar working on Molecular Biology, Biophysics and Genetics. According to data from OpenAlex, Steven A. Haney has authored 25 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Biophysics and 7 papers in Genetics. Recurrent topics in Steven A. Haney's work include Cell Image Analysis Techniques (9 papers), RNA Interference and Gene Delivery (4 papers) and Bacterial Genetics and Biotechnology (4 papers). Steven A. Haney is often cited by papers focused on Cell Image Analysis Techniques (9 papers), RNA Interference and Gene Delivery (4 papers) and Bacterial Genetics and Biotechnology (4 papers). Steven A. Haney collaborates with scholars based in United States, Canada and Germany. Steven A. Haney's co-authors include James R. Broach, Dale L. Oxender, Jing Pan, Peter LaPan, Piet A. J. de Boer, Cynthia A. Hale, Jill Platko, David Keeney, Joseph M. Calvo and Jing Zhang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Steven A. Haney

24 papers receiving 736 citations

Peers

Countries citing papers authored by Steven A. Haney

Since Specialization

Citations

This map shows the geographic impact of Steven A. Haney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Haney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Haney more than expected).

Fields of papers citing papers by Steven A. Haney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven A. Haney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Haney. The network helps show where Steven A. Haney may publish in the future.

Co-authorship network of co-authors of Steven A. Haney

This figure shows the co-authorship network connecting the top 25 collaborators of Steven A. Haney. A scholar is included among the top collaborators of Steven A. Haney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven A. Haney. Steven A. Haney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peak emission wavelength and fluorescence lifetime are coupled in far-red, GFP-like fluorescent proteins 2018 ·PLoS ONE ·(unknown), Santosh Hariharan, Qian Liu, Steven A. Haney, David W. Andrews	18
2	Abstract 5245: Identification and characterization of the IDO1 inhibitor LY3381916 2018 ·Cancer Research ·Frank C. Dorsey, Karim A. Benhadji, Lillian Sams, Debra A. Young, John F. Schindler, Karen Huss, Alexander Nikolayev, Carmine Carpenito, David K. Clawson, (unknown), Andrew L. Faber, James E. Thomas, Steven A. Haney, (unknown), William T. McMillen, Tod Smeal, Daniel J. Sall, Michael Kalos, Sandaruwan Geeganage, James R. Henry	13
3	High-Content Screening Approaches That Minimize Confounding Factors in RNAi, CRISPR, and Small Molecule Screening 2017 ·Methods in molecular biology ·Steven A. Haney	3
4	Biologically Relevant Heterogeneity: Metrics and Practical Insights 2017 ·SLAS DISCOVERY ·Albert Gough, Andrew M. Stern, John Maier, Timothy R. Lezon, Tongying Shun, Chakra Chennubhotla, Mark E. Schurdak, Steven A. Haney, D. Lansing Taylor	55
5	Rapid Assessment and Visualization of Normality in High-Content and Other Cell-Level Data and Its Impact on the Interpretation of Experimental Results 2014 ·SLAS DISCOVERY ·Steven A. Haney	7
6	A Kinome-Wide siRNA Screen Identifies Multiple Roles for Protein Kinases in Hypoxic Stress Adaptation, Including Roles for IRAK4 and GAK in Protection against Apoptosis in VHL–/– Renal Carcinoma Cells, Despite Activation of the NF-κB Pathway 2013 ·SLAS DISCOVERY ·Jing Pan, Jing Zhang, (unknown), Peter LaPan, (unknown), Brian Bates, Christopher C.J. Miller, Steven A. Haney	7
7	RNAi Screening in Primary Human Hepatocytes of Genes Implicated in Genome-Wide Association Studies for Roles in Type 2 Diabetes Identifies Roles for CAMK1D and CDKAL1, among Others, in Hepatic Glucose Regulation 2013 ·PLoS ONE ·Steven A. Haney, Juan Zhao, (unknown), (unknown), Lin T. Guey, Eric Tien	16
8	siRNA Off-Target Effects Can Be Reduced at Concentrations That Match Their Individual Potency 2011 ·PLoS ONE ·Daniel R. Caffrey, Juan Zhao, Zhili Song, Michael Schäffer, Steven A. Haney, Romesh R. Subramanian, Albert Seymour, Jason D. Hughes	69
9	Image-Based Assessment of Growth and Signaling Changes in Cancer Cells Mediated by Direct Cell-Cell Contact 2009 ·PLoS ONE ·Peter LaPan, Jing Zhang, (unknown), Ying Zhang, Robert J. Martinez, Steven A. Haney	5
10	High content screening : science, techniques and applications 2008 ·Wiley-Interscience eBooks ·Steven A. Haney	29
11	Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized 2007 ·Molecular Cancer ·Yizheng Li, Jing Pan, Jian‐Liang Li, (unknown), (unknown), (unknown), James C. Garbe, Maryann Z. Whitley, Scott A. Jelinsky, Martha R. Stampfer, Steven A. Haney	44
12	Expanding the repertoire of RNA interference screens for developing new anticancer drug targets 2007 ·Expert Opinion on Therapeutic Targets ·Steven A. Haney	11
13	Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validation 2006 ·Expert Opinion on Drug Discovery ·Steven A. Haney	1
14	High-content screening moves to the front of the line 2006 ·Drug Discovery Today ·Steven A. Haney, Peter LaPan, Jing Pan, Jing Zhang	70
15	RNAi and high-content screening in target identification and validation. 2005 ·PubMed ·Steven A. Haney	6
16	Increased retention of functional fusions to toxic genes in new two-hybrid libraries of the E. coli strain MG1655 and B. subtilis strain 168 genomes, prepared without passaging through E. coli 2003 ·BMC Genomics ·Steven A. Haney, David Keeney, Lei Chen, Soraya L. Moghazeh, Steve Projan, Beth A. Rasmussen	4
17	Genomics in Anti-Infective Drug Discovery - Getting to Endgame 2002 ·Current Pharmaceutical Design ·Steven A. Haney, Lefa Alksne, Paul M. Dunman, E. Gordon Murphy, Steven J. Projan	25
18	CAC3 ( MSI1 ) Suppression of RAS2 ^G19V Is Independent of Chromatin Assembly Factor I and Mediated by NPR1 2001 ·Molecular and Cellular Biology ·Stephen D. Johnston, Shinichiro Enomoto, Lisa Schneper, Mark McClellan, (unknown), Nathan D. Montgomery, Steven A. Haney, James R. Broach, Judith Berman	28
19	Genetic Analysis of the Escherichia coli FtsZ·ZipA Interaction in the Yeast Two-hybrid System 2001 ·Journal of Biological Chemistry ·Steven A. Haney, (unknown), Cynthia A. Hale, David Keeney, (unknown), Piet A. J. de Boer	111
20	Amino Acid Transport in Bacteria 1992 ·International review of cytology ·Steven A. Haney, Dale L. Oxender	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact